Business Insights, June 2010, Pages: 250
for many different infectiousdiseases but validation and commercialization has so far proved relatively elusive.
- Drug resistance, emerging infections and the threat of bioterrorism make the understanding
Business Insights, Nov 2011, Pages: 168
testing market?
- Who is developing new innovative products for the infectiousdisease MDx market and what paths to commercialization are they following?
- How are the different sectors of the infectious
Global Industry Analysts, Inc., Oct 2010, Pages: 659
Diagnosable 34
7. AN INSIGHT INTO APPLICATIONS OF MOLECULAR DIAGNOSTICS 35
InfectiousDiseases Testing 35
Activity in the Field 35
Identifying Multidrug Resistance 36
InfectiousDisease Treatment
Datamonitor, Dec 2010, Pages: 204
encephalitis and West Nile virus in the seven major markets and its impact on commercial opportunities Overview
Catalyst
Summary
About Datamonitor healthcare
About the InfectiousDisease pharmaceutical
Business Insights, Jan 2010, Pages: 283
Cardiology tests
Infectiousdisease tests
Drugs of abuse testing
Clinical chemistry and other rapid tests
Company profiles
Market analysis and forecasts
Chapter 1 Market overview
Summary
The shift
Takeda Pacific, Feb 2010, Pages: 144
and is Set for Growth
- Cancer Biomarkers and Tests
- Future Direction for CNS Disease Tests
- InfectiousDisease Testing
8.Appendices
- WW Populations by Diseases
- Examples of Uses of Biomarker Tests
RNCOS E-Services Private Limited, Aug 2011, Pages: 105
in the segment. The companies will not only look to develop the therapies for various diseases through in-house research, but also develop the ones acquired from other sources into full-fledged commercial forms
Datamonitor, Feb 2010, Pages: 35
characteristics
Demographics
Economics
Healthcare spend and access
The hepatitis B and C market in Turkey
BIBLIOGRAPHY
Journal papers
Websites
Other
About the InfectiousDiseases analysis team
Disclaimer
Datamonitor, March 2008, Pages: 123
needs in the infectiousdiseases market and identify opportunities for antibody product development.
- Gain an overview of the commercial outlook for antibody based products and their likely positioning
GlobalData, Dec 2011, Pages: 67
shaping and driving the global Fabry's Disease Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter
Datamonitor, Oct 2010, Pages: 196
key questions answered
- Get a comprehensive, insightfulcommercialoverview of the vaccines market
- Learn about the strategies of the Big 5 players, their strengths, weaknesses, similarities
Datamonitor, Aug 2010, Pages: 142
& InfectiousDiseases pharmaceutical analysis team
Executive Summary
Scope of the analysis
Datamonitor insight into the sexually transmitted diseases (STDs) market
Related reports
Upcoming related reports
Takeda Pacific, July 2005, Pages: 168
Patterns and Profiles Measure Complex Diseases
The Goal of `1-Cent-Per-SNP' Studies
Protein Patterns Demonstrated as Biomarkers
Making Diagnostics from Biomarkers
Commercializing Biomarker Tests
Home
Global Industry Analysts, Inc., Jan 2011, Pages: 442
Indication (2009): Percentage Breakdown of Number of Trials
for Cancer Diseases, Cardiovascular Diseases, InfectiousDiseases, Monogenic Diseases, Neurological Diseases and
Others (includes corresponding
GBI Research, Dec 2010, Pages: 198
of clinical need that are unmanageable with conventional therapeutics, such as oncology, infectiousdiseases including HIV, and autoimmune disorders. A strong product pipeline for most of the top 10
Life Science Intelligence, Inc., Jan 2011
during meals
- A fully integrated, affordable, sample-to-result platform for rapid, accurate PCR-based detection/differentiation of infectiousdisease
- Pressure-controlled Intermittent Coronary Sinus
Beachhead Consulting, Sep 2006
, splice variants, and microRNAs, combined with gene expression data, can be applied to the drug discovery process enabling many exciting applications, such as finding cures for infectiousdiseases
